Extreme leucocytosis and the risk of serious bacterial infections in febrile children.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 20308337.
- Also identified by DOI 10.1136/adc.2009.170969.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the clinical significance of extreme leucocytosis (white blood cell (WBC) count >25,000/mm(3)) as a predictor of serious bacterial infection (SBI) in children. A retrospective case-control study was conducted in a paediatric emergency department in Israel. The study evaluated children aged 3-36 months admitted to the emergency department with fever (>38 degrees C) who had a complete blood count (CBC). Children with extreme leucocytosis were identified through the laboratory database. Further, for each case patient two consecutive febrile patients with WBC counts of 15,000-24,999/mm(3) (moderate leucocytosis) served as controls (a case-control ratio of 1:2). During the study, 146 patients with extreme leucocytosis were identified and compared with 292 patients with moderate leucocytosis. SBI was found in 57 (39%) patients with extreme leucocytosis compared with 45 (15.4%) control patients (p<0.001). The most commonly found SBI was segmental or lobar pneumonia, which was diagnosed in 41 (28%) patients in the case group compared with 27 (9.2%) patients in the control group (p<0.001, OR 3.83, 95% CI 2.25 to 6.52). Children with extreme leucocytosis were more often treated with antibiotics (52.7% vs 27.7%, p<0.001) and admitted to hospital (98.6% vs 50.68%, p<0.001). In febrile children aged 3-36 months, the presence of extreme leucocytosis is associated with a 39% risk of having SBIs. The increased risk for SBI is mainly due to a higher risk for pneumonia.
Medical subject headings
- Bacterial Infections
- Fever
- Leukocytosis